首页>
外国专利>
Nítróoxýafleiður lósartans, valsartans, kandesartans, telmisartans, eprósartans og ólmesartans sem angíótensín-II viðtakatálmar til að meðhöndla hjarta- og æðasjúkdóma
Nítróoxýafleiður lósartans, valsartans, kandesartans, telmisartans, eprósartans og ólmesartans sem angíótensín-II viðtakatálmar til að meðhöndla hjarta- og æðasjúkdóma
Angiotensin II receptor blocker nitroderivatives of formula (I): ?in-line-formulae description="In-line Formulae" end="lead"?R-(Y-ONOSUB2/SUB)SUBs/SUB (I) ?in-line-formulae description="In-line Formulae" end="tail"? having wider pharmacological activity and enhanced tolerability. They can be employed for treating cardiovascular, renal and chronic liver diseases and inflammatory processes.
展开▼
机译：式（I）的血管紧张素II受体阻滞剂硝基衍生物：<？in-line-formulae description =“ In-line Formulae” end =“ lead”？> R-（Y-ONO 2 ） s （I）<？in-line-formulae description =“ In-line Formulae” end =“ tail”？>具有更广泛的药理活性和增强的耐受性。它们可用于治疗心血管，肾脏和慢性肝脏疾病以及炎症过程。
展开▼
